151 related articles for article (PubMed ID: 1190833)
1. [Mitogenic activity of melanoma extracts in leucocyte cultures (author's transl)].
Lischka G
Arch Dermatol Res (1975); 1975 Sep; 253(2):105-12. PubMed ID: 1190833
[TBL] [Abstract][Full Text] [Related]
2. Melanomas that develop within the eye inhibit lymphocyte proliferation.
Verbik DJ; Murray TG; Tran JM; Ksander BR
Int J Cancer; 1997 Nov; 73(4):470-8. PubMed ID: 9389558
[TBL] [Abstract][Full Text] [Related]
3. In vitro lymphocyte reactivity to soluble tumor extracts in Sinclair melanoma swine.
Aultman MD; Hook RR
Int J Cancer; 1979 Nov; 24(5):673-8. PubMed ID: 528082
[No Abstract] [Full Text] [Related]
4. [Immunology of melanoma].
Vanwijck R; Bernheim JL; Lejeune FJ
Acta Chir Belg; 1974 Mar; 73(2):135-88. PubMed ID: 4615541
[No Abstract] [Full Text] [Related]
5. Tumour-infiltrating lymphocytes and melanoma tumorigenesis: an insight.
Hussein MR
Br J Dermatol; 2005 Jul; 153(1):18-21. PubMed ID: 16029321
[TBL] [Abstract][Full Text] [Related]
6. [Immunological monitoring in patients with malignant melanoma (author's transl)].
Uhrík J; Jurga L; Hejj F; Cichý A; Dubivská M; Gumanová Z
Cesk Dermatol; 1980; 55(6):361-67. PubMed ID: 7460038
[No Abstract] [Full Text] [Related]
7. [Influence of autologous serum on leucocyte-migration-inhibition-test in melanomalignoma (author's transl)].
Fritz J; Grond K
Arch Dermatol Res (1975); 1977 Apr; 258(2):121-6. PubMed ID: 326202
[TBL] [Abstract][Full Text] [Related]
8. [Specific immune reactivity in patients with malignant melanoma (author's transl)].
Poljak-Blazi M; Montani D; Ferle-Vidović A; Boranić M
Lijec Vjesn; 1977 Dec; 99(12):735-8. PubMed ID: 607047
[No Abstract] [Full Text] [Related]
9. [Cellular immunity in melanomalignome (author's transl)].
Fritz J; Grond K; Tilz GP
Arch Dermatol Res (1975); 1976 Apr; 255(2):203-9. PubMed ID: 1275554
[TBL] [Abstract][Full Text] [Related]
10. Immunodiagnostics of malignant disease. VI. Electrophoretic mobility test (EMT) in malignant melanoma.
Douwes FR; Spellmann HJ; Mross K; Wolfrum DI
Oncology; 1978; 35(4):163-7. PubMed ID: 81476
[TBL] [Abstract][Full Text] [Related]
11. Demonstration of lymphocyte blastogenesis--inhibiting factors in sera of melanoma patients.
Rangel DM; Golub SH; Morton DL
Surgery; 1977 Aug; 82(2):224-32. PubMed ID: 877866
[TBL] [Abstract][Full Text] [Related]
12. In vitro lymphocyte stimulation by a soluble antigen from malignant melanoma.
Jehn UW; Nathanson L; Schwartz RS; Skinner M
N Engl J Med; 1970 Aug; 283(7):329-33. PubMed ID: 4193645
[No Abstract] [Full Text] [Related]
13. Effect of column purification on response of lymphocytes in mixed leucocyte cultures (MLC) and to blastogenic media deprived from MLCS.
Jones AL
Clin Exp Immunol; 1971 Jun; 8(6):927-39. PubMed ID: 5091618
[TBL] [Abstract][Full Text] [Related]
14. In situ analysis of the mononuclear cell infiltrate in primary malignant melanoma of the skin.
Poppema S; Bröcker EB; de Leij L; Terbrack D; Visscher T; Ter Haar A; Macher E; Thé TH; Sorg C
Clin Exp Immunol; 1983 Jan; 51(1):77-82. PubMed ID: 6219841
[TBL] [Abstract][Full Text] [Related]
15. Dendritic cell immunizations alone or combined with low doses of interleukin-2 induce specific immune responses in melanoma patients.
Escobar A; López M; Serrano A; Ramirez M; Pérez C; Aguirre A; González R; Alfaro J; Larrondo M; Fodor M; Ferrada C; Salazar-Onfray F
Clin Exp Immunol; 2005 Dec; 142(3):555-68. PubMed ID: 16297169
[TBL] [Abstract][Full Text] [Related]
16. [Comparative autoradiographic study on the stroma reaction in melanoma and basal cell epithelioma (author's transl)].
Pullmann H; Steigleder GK
Arch Dermatol Forsch; 1974; 250(2):173-6. PubMed ID: 4611352
[No Abstract] [Full Text] [Related]
17. Studies of cellular mediated immunity in malignant melanoma patients by Leukocyte Adherence Inhibition Test.
Müller S; Ernst TM
Arch Dermatol Res; 1980; 268(2):167-81. PubMed ID: 7425670
[TBL] [Abstract][Full Text] [Related]
18. Melanoma-reactive human cytotoxic T lymphocytes derived from skin biopsies of delayed-type hypersensitivity reactions induced by injection of an autologous melanoma cell line.
Waanders GA; Rimoldi D; Liénard D; Carrel S; Lejeune F; Dietrich PY; Cerottini JC; Romero P
Clin Cancer Res; 1997 May; 3(5):685-96. PubMed ID: 9815737
[TBL] [Abstract][Full Text] [Related]
19. Lymphocytes cytotoxic to uveal and skin melanoma cells from peripheral blood of ocular melanoma patients.
Kan-Mitchell J; Liggett PE; Harel W; Steinman L; Nitta T; Oksenberg JR; Posner MR; Mitchell MS
Cancer Immunol Immunother; 1991; 33(5):333-40. PubMed ID: 1831067
[TBL] [Abstract][Full Text] [Related]
20. [The characterization of tumour-associated membrane-bound antigens and their implementation in the treatment of malignant melanoma (author's transl)].
Kokoschka EM
Wien Klin Wochenschr Suppl; 1979; 97():3-32. PubMed ID: 106559
[No Abstract] [Full Text] [Related]
[Next] [New Search]
